This content is in French.
Pediatric leukemia: what if everything happens at the cell surface?
16 février 2026
By Ana Espino | Published on February 16, 2026 | 3 min readAcute lymphoblastic leukemia (ALL) is the most common cancer in children, accounting for approximately 80% of pediatric leukemias. It is characterized by the massive proliferation of immature lymphoblasts in the bone marrow, disrupting normal hematopoiesis and leading to potentially fatal complications without prompt treatment. Owing to th
By Ana Espino | Published on February 16, 2026 | 3 min read
Acute lymphoblastic leukemia (ALL) is the most common cancer in children, accounting for approximately 80% of pediatric leukemias. It is characterized by the massive proliferation of immature lymphoblasts in the bone marrow, disrupting normal hematopoiesis and leading to potentially fatal complications without prompt treatment. Owing to therapeutic advances, survival rates now exceed 85%. However, this success still conceals significant limitations in disease management.
Acute lymphoblastic leukemia (ALL) is the most common cancer in children, accounting for approximately 80% of pediatric leukemias. It is characterized by the massive proliferation of immature lymphoblasts in the bone marrow, disrupting normal hematopoiesis and leading to potentially fatal complications without prompt treatment. Owing to therapeutic advances, survival rates now exceed 85%. However, this success still conceals significant limitations in disease management.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Insights on the Role of Sialic Acids in Acute Lymphoblastic Leukemia in Children
View the source
